Patients with COPD and established cardiovascular disease have more MACEs and seek less preventive cardiac care than patients with CVD alone.

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Myocardial ischemia is a drop in blood flow to the heart. Myocardial infarction, or heart attack, occurs when death or damage occurs in the muscle tissue of the heart due to low blood supply.

Most trials that have shown a benefit of beta-blocker treatment after myocardial infarction included patients with large myocardial infarctions and were conducted in an era before modern biomarker ...

The safety and efficacy of empagliflozin in patients who have had acute myocardial infarction are unknown. In this event-driven, double-blind, randomized, placebo-controlled trial, we assigned ...

Heart failure (HF), a common complication of myocardial infarction (MI), occurs in 14%-36% of hospitalized patients. Patients with HF can present with a wide spectrum of clinical severity ...

NSTEMI stands for non-ST segment elevation myocardial infarction, which is a type of heart attack. Compared to the more common type of heart attack known as STEMI, an NSTEMI is typically less ...

Cardiogenic shock is still a dreadful and severe complication of acute myocardial infarction (AMI) that occurs in approximately 7% of all patients. These patients have poor outcomes and in ...